| TSRO Market Cap History Table | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Below is a table of the TSRO market cap history going back to 6/28/2012:
Also see: TSRO Shares Outstanding History and TSRO YTD Return |
TSRO Market Cap History — Tesaro Capitalization Over Time
As of 10/29/2018 Tesaro has a market cap of 1.70 billion. Investors often follow the TSRO market cap history to compare the size of the company over time.
This page shows TSRO market capitalization trends over time, with 27 market cap datapoints presented, dating back to 6/28/2012.
| TSRO Market Cap History Chart | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||
TSRO Historical Market Cap: +27.43% CAGR 
Mouse over chart for data details
| |||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| TSRO Stock Price Chart |
| About Tesaro Inc |
| TESARO is a biopharmaceutical company focused on providing therapies to people facing cancer. Co.'s primary focus is to develop treatments for tumors using various approaches, including small molecules and immuno-oncology antibodies, as monotherapies or in combinations. Co.'s products are: ZEJULA® (niraparib), which is for the maintenance treatment of women with recurrent epithelial ovarian, fallopian tube, or primary peritoneal cancer; and VARUBI® (rolapitant), a neurokinin, receptor antagonist for the prevention of chemotherapy induced nausea and vomiting. Co. is evaluating its immuno-oncology anti-tumor agents in combination studies with niraparib and other anti-tumor agents. We show 27 historical shares outstanding datapoints in our TSRO shares outstanding history coverage, used to compute TSRO market cap on those dates. Understanding the changing numbers of shares outstanding, the changing share price, and the resulting changing TSRO market cap history over the course of time is important for investors interested in comparing TSRO's market cap history versus its peers. Many "beginner" or "novice" investors will look at one stock trading at a price of $10 per share and another trading at a price of $20 per share and think the latter company is worth twice as much. Of course, that is a completely meaningless comparison without also knowing how many shares outstanding there are for each of the two companies, and then calculating their respective market caps. Comparing the share price of TSRO versus a peer is one thing; comparing TSRO market cap versus a peer is a completely different story. Furthermore, via fluctuation both in per-share price and in the number of shares outstanding (via issuance of new shares over time, the repurchase of existing shares), the market cap for a company like TSRO can fluctuate over the course of history. With this page we aim to empower investors researching TSRO by allowing them to research the TSRO market cap history. |
| TSRO Current Stock Quote |
Quotes delayed 20 minutes  Free TSRO Email Alerts:
Get Dividend Alerts 
Get SEC Filing Alerts
|
| Video: The Importance of Market Cap | |
|
Video: The Importance of Market Cap
| TSRO Share Performance |
| Market Cap Peers |
| Tesaro (TSRO) is categorized under the Healthcare sector; to help you further research historical market cap numbers, below are some other companies in the same sector:
TSVT Market Cap History TTNP Market Cap History TTOO Market Cap History TTPH Market Cap History TVRD Market Cap History TVTX Market Cap History TVTY Market Cap History TWST Market Cap History TXAC Market Cap History TXG Market Cap History More Healthcare companies » |
TSRO Market Cap History | www.MarketCapHistory.com | Copyright © 2017 - 2026, All Rights Reserved
Nothing in MarketCapHistory.com is intended to be investment advice, nor does it represent the opinion of, counsel
from, or recommendations by BNK Invest Inc. or any of its affiliates, subsidiaries or partners.
None of the information contained herein constitutes a recommendation that any particular security, portfolio,
transaction, or investment strategy is suitable for any specific person. All viewers agree that under no
circumstances will BNK Invest, Inc,. its subsidiaries, partners, officers, employees, affiliates, or agents be held
liable for any loss or damage caused by your reliance on information obtained. By visiting, using or viewing this site, you
agree to the following Full Disclaimer & Terms of Use and
Privacy Policy. Video widget and market videos powered by Market News Video. Quote and option data delayed at
least 15 minutes; stock quote data powered by Ticker Technologies, and Mergent.
